Articles dans des revues avec comité de lecture (373)
  1. 93. Rorive, S., D'Haene, N., Fossion, C., Delpierre, I., Abarguia, N., Avni, E., Decaestecker, C., & Salmon, I. (2010). Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. European journal of endocrinology, 162(6), 1107-1115. doi:10.1530/EJE-09-1103
  2. 94. Noval Rivas, M., Hazzan, M., Weatherly, K., Gaudray, F., Salmon, I., & Braun, M. Y. (2010). NK cell regulation of CD4 T cell-mediated graft-versus-host disease. The Journal of immunology, 184(12), 6790-6798. doi:10.4049/jimmunol.0902598
  3. 95. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  4. 96. D'Haene, N., Salik, D., Hanset, M., & Salmon, I. (2010). A propos d'un cas de maladie de von Hippel-Lindau diagnostiqué lors de l'autopsie. Revue médicale de Bruxelles, 31(2), 122-126.
  5. 97. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  6. 98. Flamez, D., Roland, I., Berton, A., Kutlu, B., Dufrane, D., Beckers, M. C., De Waele, E., Rooman, I., Bouwens, L., Clark, A., Lonneux, M., Jamar, J. F., Goldman, S., Marechal, D., Goodman, N., Gianello, P., Van Huffel, C., Salmon, I., & Eizirik, D. L. (2010). A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gamma as a pancreatic beta cell-specific biomarker. Diabetologia, 53(7), 1372-1383. doi:10.1007/s00125-010-1714-z
  7. 99. Poncelet, L., Jolly, S., Salmon, I., & Summers, B. (2010). Lesion ressembling central pontine myelinolysis in a cat. Veterinary pathology, 48(3), 751-753.
  8. 100. Marechal, R., De Schutter, J., Nagy, N., Demetter, P., Lemmers, A., Devière, J., Salmon, I., Tejpar, S., & Van Laethem, J.-L. (2010). Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC cancer, 10, 340. doi:10.1186/1471-2407-10-340
  9. 101. Decaestecker, C., Moles Lopez, X., D'Haene, N., Roland, I., Guendouz, S., Duponchelle, C., Berton, A., Debeir, O., & Salmon, I. (2009). Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis. Proteomics, 9(19), 4478-4494. doi:10.1002/pmic.200800936
  10. 102. Noval Rivas, M., Weatherly, K., Hazzan, M., Vokaer, B., Dremier, S., Gaudray, F., Goldman, M., Salmon, I., & Braun, M. Y. (2009). Reviving function in CD4+ T cells adapted to persistent systemic antigen. The Journal of immunology, 183(7), 4284-4291. doi:10.4049/jimmunol.0901408
  11. 103. Palm, T., Figarella-Branger, D., Chapon, F., Lacroix, C., Gray, F., Scaravilli, F., Ellison, D., Salmon, I., Vikkula, M., & Godfraind, C. (2009). Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis. Cancer, 115(17), 3955-3968. doi:10.1002/cncr.24476
  12. 104. Mathieu, A., Weynand, B., Verbeken, E., Da Silva, S., Decaestecker, C., Salmon, I., & Demetter, P. (2009). Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer. Lung cancer, 1301, 152-162. doi:10.1016/j.lungcan.2009.09.003
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 42 43 44 45 46 Suivant >>